Companion Diagnostics Market in LAMEA is expected to register a CAGR of 20.7% during the forecast period (2019-2025) - KBV Research

Published Date: 31-Aug-2019

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

According to a new report LAMEA Companion Diagnostics Market, published by KBV research, the LAMEA Companion Diagnostics Market would witness market growth of 20.7% CAGR during the forecast period (2019-2025).

The Brazil market dominated the LAMEA Polymerase chain reaction (PCR) Market by Country in 2018, growing at a CAGR of 20.2 % during the forecast period. The Argentina market is expected to witness a CAGR of 22.5% during (2019 - 2025). Additionally, The UAE market is expected to witness a CAGR of 20.5% during (2019 - 2025).

The Oncology market dominated the Saudi Arabia Companion Diagnostics Market by Indication in 2018, growing at a CAGR of 22.3 % during the forecast period. The Neurology market is expected to witness a CAGR of 19.4% during (2019 - 2025).

The Breast Cancer market dominated the Nigeria Companion Diagnostics Market by Cancer Type in 2018, growing at a CAGR of 22.9 % during the forecast period. The Colorectal Cancer market is expected to witness a CAGR of 23.6% during (2019 - 2025).

Full Report:

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Agilent Technologies, Inc., Almac Group, ARUP Laboratories, Inc., Abbott Laboratories (Abbott Laboratories Molecular, Inc.), Danaher Corporation, Thermo Fisher Scientific, Inc., Hologic, Inc., Novartis AG, Illumina, Inc., Qiagen N.V.

LAMEA Companion Diagnostics Market Segmentation

By Technology

  • Immunohistochemistry
  • Polymerase chain reaction (PCR)
  • Next generation sequencing (NGS)
  • In Situ Hybridization and
  • Other Technology

By Indication

  • Oncology
  • Neurology and
  • Other Indications

By Cancer Type

  • Breast Cancer
  • Colorectal Cancer
  • Lung Cancer
  • Blood Cancer and
  • Other Cancer Type

By Country

  • Brazil Companion Diagnostics Market
  • Argentina Companion Diagnostics Market
  • UAE Companion Diagnostics Market
  • Saudi Arabia Companion Diagnostics Market
  • South Africa Companion Diagnostics Market
  • Nigeria Companion Diagnostics Market
  • Rest of LAMEA Companion Diagnostics Market

Companies Profiled

  • Agilent Technologies, Inc.
  • Almac Group
  • ARUP Laboratories, Inc.
  • Abbott Laboratories (Abbott Laboratories Molecular, Inc.)
  • Danaher Corporation
  • Thermo Fisher Scientific, Inc.
  • Hologic, Inc.
  • Novartis AG
  • Illumina, Inc.
  • Qiagen N.V.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Companion Diagnostics Market Related Reports:

Global Market

North America Market

Europe Market

Asia Pacific Market

Request For Sample

Why Choose Us

  • 24/7 Research support
    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Information security
    Your personal and confidential information is safe and secure.